Wednesday, October 7, 2015  
United States
United Kingdom
skip to the main content area of this page

A Full Service Oncology CRO

Celebrating over Thirty Years of Service to Oncology

Theradex® is an international contract research organization providing complete professional services for the clinical research and development of pharmaceutical compounds, medical devices and diagnostic tests in the areas of oncology and life-threatening diseases. Theradex® conducts studies which lead to marketing approval of significant medical advances; and has built a reputation on assuring the scientific objectivity and meticulous quality control that fulfills all regulatory requirements. Our expertise is also available to assist client personnel in expedited development planning and execution.

Over Thirty Year Contract with NCI

For over thirty years, Theradex has held the Clinical Trials Monitoring Service Contract for the National Cancer Institute in the United States. In that time, we have not only gained a wealth of experience in the treatment of cancer and allied diseases, but have also formed long-standing relationships with oncology thought-leaders, academic and non-academic institutions, regulatory personnel and, most importantly, our clients. We demonstrate time and time again our flexibility and commitment to quality, which larger CROs are often unable to attain. On behalf of our clients and through our global development capability, Theradex® provides a comprehensive array of services.

Visit our Service Offerings

Firm Experience

Theradex® has provided services for over 1000 oncology protocols for compounds in all phases of development.  Our clients include the US National Cancer Institute and sponsors ranging from virtual biotech to international pharmaceutical companies.

Our long-standing collaboration with NCI enables Theradex® to gain experience in new therapeutic approaches as they emerge.

Contact us


Theradex® does not engage in any agreements that give Theradex® a biased interest in the outcome of the project.  This avoids the creation of a conflict of interest or bias that might arise if Theradex® were to profit from the development of our clients' compounds.

About Theradex

Our Philosophy

The Theradex® philosophy keeps our clients' interests as our primary objective.  All projects are pursued with scientific objectivity, cost economy and time to market in mind.  The Theradex® philosophy emphasizes the importance of developing effective new drug therapies, and not our financial interest.  We are committed to giving objective opinions on your strategies and protocol design.

Thinking Big  
Clinical Relationships
Theradex® has formed long-standing relationships with oncology thought leaders in both academic and non-academic institutions world wide. As a result of holding both government and commercial contracts, Theradex® is able to continually assess the performance of academic and non-academic oncology investigators in clinical trial execution.